Compare QURE & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QURE | DFH |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | QURE | DFH |
|---|---|---|
| Price | $23.37 | $20.78 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | ★ $56.25 | $26.00 |
| AVG Volume (30 Days) | ★ 1.9M | 430.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142.93 | $3.26 |
| P/E Ratio | ★ N/A | $7.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.76 | $16.59 |
| 52 Week High | $71.50 | $31.50 |
| Indicator | QURE | DFH |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 61.36 |
| Support Level | $20.17 | $20.12 |
| Resistance Level | $26.97 | $21.55 |
| Average True Range (ATR) | 2.25 | 0.94 |
| MACD | -0.26 | 0.20 |
| Stochastic Oscillator | 38.75 | 80.64 |
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.